Indication: 1. Used to treat viral or fungal infections that are difficult to control with certain antibiotics (such as herpes zoster, epidemic encephalitis B, Candida albicans infection, viral myocarditis, etc.). 2. Used as an adjuvant therapy for malignant tumors (mainly used for lung cancer, nasopharyngeal carcinoma, breast cancer, osteosarcoma, etc.). 3. Used for immunodeficiency diseases (such as eczema, thrombocytopenia, multiple infection syndrome and chronic skin and mucosal fungal diseases), and also has a certain therapeutic effect on autoimmune diseases.

Indication: 1. Used to treat viral or fungal infections that are difficult to control with certain antibiotics (such as herpes zoster, epidemic encephalitis B, Candida albicans infection, viral myocarditis, etc.). 2. Used as an adjuvant therapy for malignant tumors (mainly used for lung cancer, nasopharyngeal carcinoma, breast cancer, osteosarcoma, etc.). 3. Used for immunodeficiency diseases (such as eczema, thrombocytopenia, multiple infection syndrome and chronic skin and mucosal fungal diseases), and also has a certain therapeutic effect on autoimmune diseases.

Indication: 1. Used to treat viral or fungal infections that are difficult to control with certain antibiotics (such as herpes zoster, epidemic encephalitis B, Candida albicans infection, viral myocarditis, etc.). 2. Used as an adjuvant therapy for malignant tumors (mainly used for lung cancer, nasopharyngeal carcinoma, breast cancer, osteosarcoma, etc.). 3. Used for immunodeficiency diseases (such as eczema, thrombocytopenia, multiple infection syndrome and chronic skin and mucosal fungal diseases), and also has a certain therapeutic effect on autoimmune diseases.

Indication: It is the first-line drug for the treatment of various solid tumors. Combination with VP-16 (EP regimen) is the first-line treatment for SCLC or NSCLC. Combination with MMC, IFO (IMP regimen), or NVB is the commonly used regimen for the treatment of NSCLC. Combination chemotherapy based on DDP is also the main treatment for advanced ovarian cancer, osteosarcoma and neuroblastoma. Combination with ADM, CTX, etc. is effective for squamous cell carcinoma and transitional cell carcinoma in multiple sites, such as head and neck, cervix, esophagus and urinary system tumors. PVB (DDP, VLB, BLM) can treat most stage IV non-spermatogonia testicular cancers, with a remission rate of 50℅ to 80℅. In addition, this product is a radiotherapy sensitizer. It is currently widely used in foreign countries for local radiotherapy of stage IV inoperable NSCLC, which can improve efficacy and survival.

Indication: It has a wide anti-tumor spectrum and is clinically used to treat testicular malignant tumors. It has good effects on embryonal tumors and seminoma, and has no cross-resistance with commonly used drugs. It has good effects on ovarian cancer, breast cancer and bladder cancer. It also has certain effects on head and neck cancer, lung cancer, esophageal cancer, malignant melanoma, malignant lymphoma, soft tissue sarcoma and cancerous pleural effusion and ascites. It has good effects when used in combination with other anticancer drugs.

Indication: This product is a first-line drug for the treatment of various solid tumors. Combination with VP-16 (EP regimen) is a first-line regimen for the treatment of SCLC or NSCLC. Combination with MMC, IFO (IMP regimen), or NVB is a commonly used regimen for the treatment of NSCLC. Combination chemotherapy based on DDP is also the main treatment for advanced ovarian cancer, osteosarcoma and neuroblastoma. Combination with ADM, CTX, etc. is effective for squamous cell carcinoma and transitional cell carcinoma in multiple sites, such as head and neck, cervix, esophagus and urinary system tumors. "PVB" (DDP, VLB, BLM) can treat most stage IV non-spermatogonia testicular cancers with a remission rate of 50% to 80%. In addition, this product is a radiotherapy sensitizer. It is currently widely used in foreign countries for local radiotherapy of stage IV inoperable NSCLC, which can improve efficacy and survival.

Indication: Used for various sarcomas such as nasopharyngeal carcinoma, ovarian cancer, bladder cancer, testicular cancer, lymphosarcoma, reticular cell sarcoma, etc.

Indication: Used for various sarcomas such as nasopharyngeal carcinoma, ovarian cancer, bladder cancer, testicular cancer, lymphosarcoma, reticular cell sarcoma, etc.